Psoriasis Drugs Market Size, Share, Trends, Growth, and Regional Forecasts 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Psoriasis Drugs Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Drug Class Adoption Analysis
   2. Regulatory Landscape
   3. Pipeline Assessment
   4. Disease Epidemiology
   5. Key Deals and Mergers
   6. PESTLE Analysis
   7. Value Chain Analysis
   8. Porter’s Five Force Analysis
4. Global Psoriasis Drugs Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   3. Global Psoriasis Drugs Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
         1. Interleukin Inhibitors
         2. Corticosteroids
         3. Anti-inflammatory
         4. Glucocorticoids
         5. Tnf alfa Inhibitor
         6. Others
      4. Market Attractiveness Analysis: Drug Class
   4. Global Psoriasis Drugs Market Outlook: Mode of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Mode of Administration, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Mode of Administration, 2025-2032
         1. Topical
         2. Oral
         3. Injectable
         4. Others
      4. Market Attractiveness Analysis: Mode of Administration
   5. Global Psoriasis Drugs Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
         1. Guttate Psoriasis
         2. Inverse Psoriasis
         3. Pustular Psoriasis
         4. Erythrodermic Psoriasis
         5. Plaque Psoriasis
         6. Others
      4. Market Attractiveness Analysis: Indication
   6. Global Psoriasis Drugs Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
         1. Hospital Pharmacies
         2. Retail Pharmacies
         3. e-Commerce
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Psoriasis Drugs Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
   3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Psoriasis Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Mode of Administration
      4. By Indication
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast By Country, 2025-2032
      1. U.S.
      2. Canada
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Interleukin Inhibitors
      2. Corticosteroids
      3. Anti-inflammatory
      4. Glucocorticoids
      5. Tnf alfa Inhibitor
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Mode of Administration, 2025-2032
      1. Topical
      2. Oral
      3. Injectable
      4. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Guttate Psoriasis
      2. Inverse Psoriasis
      3. Pustular Psoriasis
      4. Erythrodermic Psoriasis
      5. Plaque Psoriasis
      6. Others
   7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. e-Commerce
   8. Market Attractiveness Analysis
7. Europe Psoriasis Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Mode of Administration
      4. By Indication
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Interleukin Inhibitors
      2. Corticosteroids
      3. Anti-inflammatory
      4. Glucocorticoids
      5. Tnf alfa Inhibitor
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Mode of Administration, 2025-2032
      1. Topical
      2. Oral
      3. Injectable
      4. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Guttate Psoriasis
      2. Inverse Psoriasis
      3. Pustular Psoriasis
      4. Erythrodermic Psoriasis
      5. Plaque Psoriasis
      6. Others
   7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. e-Commerce
   8. Market Attractiveness Analysis
8. East Asia Psoriasis Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Mode of Administration
      4. By Indication
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Interleukin Inhibitors
      2. Corticosteroids
      3. Anti-inflammatory
      4. Glucocorticoids
      5. Tnf alfa Inhibitor
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Mode of Administration, 2025-2032
      1. Topical
      2. Oral
      3. Injectable
      4. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Guttate Psoriasis
      2. Inverse Psoriasis
      3. Pustular Psoriasis
      4. Erythrodermic Psoriasis
      5. Plaque Psoriasis
      6. Others
   7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. e-Commerce
   8. Market Attractiveness Analysis
9. South Asia & Oceania Psoriasis Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Mode of Administration
      4. By Indication
      5. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Interleukin Inhibitors
      2. Corticosteroids
      3. Anti-inflammatory
      4. Glucocorticoids
      5. Tnf alfa Inhibitor
      6. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Mode of Administration, 2025-2032
      1. Topical
      2. Oral
      3. Injectable
      4. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Guttate Psoriasis
      2. Inverse Psoriasis
      3. Pustular Psoriasis
      4. Erythrodermic Psoriasis
      5. Plaque Psoriasis
      6. Others
   7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. e-Commerce
   8. Market Attractiveness Analysis
10. Latin America Psoriasis Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Drug Class
       3. By Mode of Administration
       4. By Indication
       5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
       1. Interleukin Inhibitors
       2. Corticosteroids
       3. Anti-inflammatory
       4. Glucocorticoids
       5. Tnf alfa Inhibitor
       6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Mode of Administration, 2025-2032
       1. Topical
       2. Oral
       3. Injectable
       4. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
       1. Guttate Psoriasis
       2. Inverse Psoriasis
       3. Pustular Psoriasis
       4. Erythrodermic Psoriasis
       5. Plaque Psoriasis
       6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. e-Commerce
    8. Market Attractiveness Analysis
11. Middle East & Africa Psoriasis Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Drug Class
       3. By Mode of Administration
       4. By Indication
       5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
       1. Interleukin Inhibitors
       2. Corticosteroids
       3. Anti-inflammatory
       4. Glucocorticoids
       5. Tnf alfa Inhibitor
       6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Mode of Administration, 2025-2032
       1. Topical
       2. Oral
       3. Injectable
       4. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
       1. Guttate Psoriasis
       2. Inverse Psoriasis
       3. Pustular Psoriasis
       4. Erythrodermic Psoriasis
       5. Plaque Psoriasis
       6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. e-Commerce
    8. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Janssen Biotech, Inc.
          1. Overview
          2. Segments and Drug Class
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Novartis International Ltd.
       3. Amgen Inc.
       4. Pfizer Inc.
       5. Takeda Pharmaceutical Company Ltd.
       6. Merck & Co, Inc.
       7. AbbVie Inc.
       8. Eli Lilly and Company
       9. Boehringer Ingelheim GmbH
       10. Sun Pharmaceutical Industries Ltd.
       11. Johnson & Johnson
       12. LEO Pharma
       13. UCB
       14. AstraZeneca
       15. Celgene Corporation
       16. Arcutis Biotherapeutics, Inc. 
       17. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations